Stocks Health care BON
NASDAQ · Health careBon Natural Life Ltd (BON)
Bon Natural Life Ltd reported revenue of $18.7M in fiscal 2025, down 21.7% from a year earlier. It posted a net loss of $2M. Operating cash flow minus capital spending left $134.3K of free cash flow in fiscal 2025. At September 30, 2025 it held $6.3M in cash against $1.9M of debt. Its latest periodic report to the SEC is the annual report (foreign issuer) (20-F) filed on January 23, 2026.
Key facts about Bon Natural Life Ltd
- Net worth
- Bon Natural Life Ltd has a market value (market cap) of $9.3M at the latest share price, and shareholders' equity of $57.6M on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Revenue and profit
- In fiscal 2025 revenue was $18.7M (-21.7% year on year), with a net loss of $2M.
- Cash flow
- In fiscal 2025 operations brought in $141.1K of cash; after $6.8K of capital spending, free cash flow was $134.3K.
- Latest report
- The latest periodic report (annual report (foreign issuer), 20-F) was filed with the SEC on January 23, 2026 and covers the period to September 30, 2025. Open on SEC EDGAR
What Bon Natural Life Ltd does
Bon Natural Life Ltd is registered with the SEC under industry code SIC 2833 (Medicinal Chemicals & Botanical Products). Its shares trade on NASDAQ under the ticker BON.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $18.7M | -$2M | -$0.72 | $134.3K |
| 2024 | $23.8M | $398.2K | $4.14 | -$7.7M |
| 2023 | $29.5M | $4.6M | $124.92 | -$678.8K |
| 2022 | $29.9M | $6.2M | $185.63 | -$214.8K |
| 2021 | $25.5M | $4.6M | $170.58 | $4M |
| 2021 | $18.2M | $3M | $145.49 | $2.6M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Where BON ranks in Health care
Latest SEC filings
What Bon Natural Life Ltd has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 23, 2026
- March 19, 2026
- February 17, 2026
- January 23, 2026Annual report (foreign issuer) 20-F · period to September 30, 2025Revenue fell 22% to $18.7M versus the prior year; diluted EPS -$0.72 versus $4.14.
- December 10, 2025
- November 25, 2025
- November 14, 2025
- November 10, 2025Form F-3/A filing F-3/A
- October 16, 2025Form F-3 filing F-3
- September 29, 2025
Insider trades
What the people running Bon Natural Life Ltd did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Questions about BON
What does Bon Natural Life Ltd do?
Bon Natural Life Ltd is a company in the Health care sector, listed on NASDAQ as BON. Its shares trade on NASDAQ under the ticker BON.
What is Bon Natural Life Ltd's net worth?
Bon Natural Life Ltd has a market value (market cap) of $9.3M at the latest share price, and shareholders' equity of $57.6M on its balance sheet at September 30, 2025. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Bon Natural Life Ltd profitable?
No. In fiscal 2025 it reported a net loss of $2M on revenue of $18.7M.
How much revenue does Bon Natural Life Ltd make?
In fiscal 2025 Bon Natural Life Ltd reported revenue of $18.7M. That is 21.7% less than a year earlier.
When did Bon Natural Life Ltd last report?
Its most recent periodic report is the annual report (foreign issuer) (20-F) filed on January 23, 2026. It covers the period to September 30, 2025. Its newest filing of any kind is the foreign issuer update from September 23, 2026.
Similar companies
Compare BON with
Follow BON
Get an email when Bon Natural Life Ltd files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Bon Natural Life Ltd tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.